Charles is a co-founder of Mereo.
He has over 25 years’ experience in biopharmaceuticals and oversees all legal, risk, compliance and corporate governance matters for the Company.
Charles began his career as a lawyer at Freshfields in London specialising in corporate finance before joining the global financial services group, Nomura, in 1998 where he worked for Nomura’s life science investment team investing in biotechnology companies in the US and Europe. Prior to joining Mereo in 2015, Charles was part of Phase4 Partners’ MBO from Nomura.
Charles is currently a trustee of the Rainbow Trust Children’s Charity, a UK based charity supporting families who have a child aged 0-18 with a life threatening or terminal illness. He formerly sat on the board of the Mayor of London’s Digital, Creative, Science and Technology (DCST) Working Group, as part of the London Enterprise Panel, between 2013 and 2016.
Charles holds an LLB (Hons) from the University of Hull, UK.
What is Charles Sermon's net worth?
The estimated net worth of Charles Sermon is at least $489.61 thousand as of September 12th, 2024. Sermon owns 240,007 shares of Mereo BioPharma Group stock worth more than $489,614 as of December 5th. This net worth estimate does not reflect any other investments that Sermon may own. Additionally, Sermon receives an annual salary of $625,790.00 as General Counsel at Mereo BioPharma Group. Learn More about Charles Sermon's net worth.
How old is Charles Sermon?
Sermon is currently 55 years old. There are 7 older executives and no younger executives at Mereo BioPharma Group. The oldest executive at Mereo BioPharma Group is Dr. John A. Lewicki Ph.D., Chief Scientific Officer, who is 72 years old. Learn More on Charles Sermon's age.
What is Charles Sermon's salary?
As the General Counsel of Mereo BioPharma Group plc - Sponsored ADR, Sermon earns $625,790.00 per year. The highest earning executive at Mereo BioPharma Group is Dr. Denise Vera Scots-Knight Ph.D., Co-Founder, CEO & Executive Director, who commands a salary of $890,560.00 per year. Learn More on Charles Sermon's salary.
How do I contact Charles Sermon?
Has Charles Sermon been buying or selling shares of Mereo BioPharma Group?
Charles Sermon has not been actively trading shares of Mereo BioPharma Group within the last three months. Most recently, Charles Sermon sold 9,980 shares of the business's stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $4.47, for a transaction totalling $44,610.60. Following the completion of the sale, the general counsel now directly owns 240,007 shares of the company's stock, valued at $1,072,831.29. Learn More on Charles Sermon's trading history.
Who are Mereo BioPharma Group's active insiders?
